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Objectives To determine risk factors for body image dissatisfaction among pediatric patients with inflammatory
bowel disease (IBD).
Study designWe performed a cross-sectional study of children aged 9-18 years in the IBD Partners Kids & Teens
cohort. Participants completed surveys including demographics, disease characteristics and activity indices, and
psychosocial outcomes measured by IMPACT-III questionnaires. We defined body image dissatisfaction if partic-
ipants answered “I look awful” or “I look bad.” Bivariate analyses assessed associations between body image
dissatisfaction and demographic, disease-related and psychosocial factors; logistic regression models evaluated
associations between risk factors and body image dissatisfaction.
Results IMPACT-III was completed by 664patients,with 74 (11.1%) reporting body image dissatisfaction. Patients
with body imagedissatisfactionweremore likely to be female (P< .01), older (median age15 vs 13 years,P< .01), and
diagnosedwith IBD at an older age (12 vs 10 years,P< .01). Thosewith body image dissatisfaction had greater body
mass indexpercentile (P= .02),more active disease (P< .01),more current steroid use (P< .01), andmoredepression
and anxiety (P < .01). Female sex (OR 2.31; 95%CI 1.22-4.39), depression (OR 4.73; 95%CI 2.41-9.26), and anxiety
(OR 5.42; 95% CI 2.48-11.80) were independently associated with body image dissatisfaction.
Conclusions In this cohort, risk factors for body image dissatisfaction include female sex, older age at diagnosis,
active disease, current steroid use, greater body mass index, and comorbid mood disorder. Interventions targeting
modifiable risk factors for body image dissatisfaction may improve quality of life in pediatric patients with body im-
age dissatisfaction. (J Pediatr 2020;223:68-72).I
nflammatory bowel diseases (IBD), which include Crohn’s disease (CD) and ulcerative colitis (UC), are chronic conditions
characterized by relapsing and remitting inflammation of the gastrointestinal tract, with a combined estimated incidence in
the US of 24.3 per 100 000 person-years.1 Although new diagnoses can be made at any age, 20% of CD and 12% of UC cases
are diagnosed before the age of 20 years. Periadolescent patients with IBD face risks of growth failure and delayed puberty due to
ongoing inflammation, poor nutritional status, and frequent steroid exposure.1-3
Similar to many chronic disease states, IBD confers a greater risk of poor psychosocial outcomes, including anxiety, depres-
sion, poor self-esteem, and worse health-related quality of life (HRQoL).4 Chronic disease states also have been associated with
body image dissatisfaction, which is defined as negative perceptions a person has about his or her body and is influenced by
factors like body shape and appearance, attitudes toward weight gain, and cultural norms regarding an “ideal” body.5,6
Studies of risk factors for body image dissatisfaction among pediatric populations with chronic diseases have had conflicting
results. One study identified boys with any chronic disease as having a greater risk of altered body image; a second suggested
girls with physical problems of high visibility were at greater risk.7 A large study of adolescents with many chronic conditionsFrom the 1Department of Internal Medicine, University of
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related chronic health conditions, such as type 1 diabetes,
cystic fibrosis (CF), and IBD.9
Clarifying associations with body image dissatisfaction in
specific chronic disease populations, such as IBD, could
help better tailor early disease-specific interdisciplinary treat-
ment strategies to improve HRQoL. Therefore, we sought to
determine the prevalence of and determine risk factors for
body image dissatisfaction among patients with IBD.
Methods
We conducted a cross-sectional study of all participants aged
9-18 years enrolled in IBD Partners Kids & Teens.3,10 The
IBD Partners Kids & Teens cohort began recruitment in
August 2013. The development of this cohort has been previ-
ously reported.11 Children and their parents complete bian-
nual questionnaires, which include demographic
information, current IBD-related medications, information
on disease characteristics, type, and activity (either short
CDAI [pediatric Crohn Disease Activity Index] or pediatric
Ulcerative Colitis Activity Index), and questions from
PROMIS (Patient-Reported Outcome Measurement Infor-
mation System), which was developed as a National Institutes
of Health initiative to measure the physical, social, and
emotional health concerns of patients with chronic dis-
eases.11,12 Beginning at age 9 years, patients enrolled in the
cohort complete patient-reported outcome reports directly;
parent proxy is used before this age. If a participant filled
out multiple surveys, their first response after age 9 was
included in our analysis.
Psychosocial PROMIS values are reported as T scores,
which are standardized scores representing a reference pedi-
atric population with a mean of 50 and SD of 10. A T score
>50 indicates greater levels of the symptom or trait being
measured. A change of 2-3 in the T-score represents a mini-
mally important difference. Pediatric PROMIS metrics for
anxiety and depression are included in the Kids & Teens
questionnaires, in addition to the IBD-specific IMPACT-III
instrument, which has been validated for children ages 9-
18 years.3 The IMPACT-III is a metric of patient-reported
HRQoL specific to the pediatric IBD population. Children
with IBD have scored worse on all psychosocial measures
in the IMPACT-III than their healthy peers.3 Among the
measures included in IMPACT-III is body image dissatisfac-
tion. We defined body image dissatisfaction as a dichoto-
mous outcome, where looking “awful” or “bad” was
selected on a 5-point Likert scale from an IMPACT-III ques-
tion asking how the child feels about the way he or she looks.
We used bivariate analyses to assess associations between
the presence of body image dissatisfaction and demographic,
disease-related, or psychosocial features. Current age, age at
diagnosis, PROMIS T scores for anxiety and depression,
and body mass index (BMI) percentiles were reported as me-
dians with IQRs. Disease classification, sex, ethnicity, ever
having had an IBD-related hospitalization, IBD-related sur-
gery, medication use, and extra-intestinal manifestationswere reported as percentages. Clinical remission was defined
by scoring <10 points on the pediatric Ulcerative Colitis Ac-
tivity Index or <150 points on the CDAI.
Logistic regression models evaluated independent associa-
tions between selected risk factors and body image dissatis-
faction. PROMIS T scores for anxiety and depression were
dichotomized using 1 minimally important difference (aver-
aged at 2.5) above the mean as the cutoff for presence of anx-
iety or depression. Thus, any patient T score above 52.5 was
considered a positive response. aORs are presented with 95%
CIs. Statistical significance was defined by P values with an
alpha less than 0.05. All analyses were performed using Stata
14.0 (STATA, College Station, Texas). The study protocol
was approved by the institutional review board at the Univer-
sity of North Carolina.
Results
A total of 664 pediatric patients completed a Kids & Teens
survey including the IMPACT-III between August 2013
and June 2017, of whom 74 (11.1%)met criteria for body im-
age dissatisfaction. Of the respondents, 75% had CD; 54%
were male; and 89% were white in ethnicity. Median age
was 13 years. A total of 55% were taking biologic therapies
at time of survey completion, and 12% were taking daily ste-
roids. Only 98 patients (14%) in this cohort reported a his-
tory of IBD-related surgery, 19 with ostomy creation and
79 with ileal pouch anal anastomoses.
There was no significant difference in the prevalence of
body image dissatisfaction between pediatric patients with
UC and those with CD, and both groups were primarily
composed of white patients (both 89%). Female patients
were significantly more likely to endorse body image dissat-
isfaction than their male counterparts (Table I, 69% vs
44%, P < .001). Pediatric patients reporting body image
dissatisfaction were older (median age 15 [IQR 12-16] vs
13 [IQR 11-15] years, P < .001) at time of survey
completion and were diagnosed with IBD at an older
median age (12 [IQR 10-14] vs 10 [IQR 8-12] years,
P < .001). Those endorsing body image dissatisfaction also
had greater BMI (P = .022). When divided into quartiles of
BMI percentile, patients in the 2 highest quartiles (50-
100th percentiles) reported increasingly high rates of body
image dissatisfaction (Figure, 16% and 20% prevalence).
The lowest rate of body image dissatisfaction was found in
Quartile 2 (25-50th percentile, 8%), with increased body
image dissatisfaction in the lowest-weight group (Quartile
1, 0-25th percentile, 9.5%).
Participants with body image dissatisfaction were more
likely to be treated with steroids than those without body im-
age dissatisfaction (18% vs 7.6%, P = .004), but there was no
significant difference in use of biologic therapies (47% vs
56%, P = .195). Those endorsing body image dissatisfaction
were significantly more likely to have ever had an IBD-related
hospitalization (68% vs 54% P = .027). There was no signif-
icant difference in history of IBD-related surgery or having an
Table I. Characteristics of the study population by presence of body image dissatisfaction
Characteristics
Body image dissatisfaction present No body image dissatisfaction
P valuen = 74 n = 590
Disease classification (% CD) 67.5 77 .088
Sex (% female) 68.9 44 <.001
Median current age, y (IQR) 15 (12-16) 13 (11-15) <.001
Median age at Dx, y (IQR) 12 (10-14) 10 (8-12) <.001
Ethnicity (% white) 89 89 .744
Median BMI percentile (IQR) 75 (50-90) 75 (50-75) .022
IBD-related hospitalization, % 67.6 54 .027
IBD-related surgery, % 21.6 14 .077
Remission,* % 42.9 74 <.001
Ostomy at baseline, % 4.1 2.7 .514
Pouch at baseline, % 20.3 13 .1
Current steroid use, % 17.6 7.6 .004
Current biologic use, % 47.3 56 .195
PROMIS† Depression T score (median, IQR) 53 (41-69) 41 (36-48) <.001
PROMIS† Anxiety T score (median, IQR) 60 (53-65) 46 (35-53) <.001
Dx, diagnosis.
*Remission defined by a pediatric Ulcerative Colitis Activity Index score <10 or a CDAI score <150.
†PROMIS.ileal–anal pouch between those with and without body image
dissatisfaction. A total of 19 patients had an ostomy, 3 with
and 16 without body image dissatisfaction; there was no sig-
nificant difference in presence of ostomy between patients
with or without body image dissatisfaction (4% vs 3%,
P = .514).
PROMIS T scores for anxiety and depression were mark-
edly greater among patients with body image dissatisfaction
(P < .001). Although pediatric patients with IBD without
body image dissatisfaction were significantly less depressed
or anxious than the reference population, those with body
image dissatisfaction were a full SD more anxious than the
















































Figure. Distribution among BMI quartiles of pediatric patients rediatric patients with IBD with body image dissatisfaction had
a significantly greater odds of reporting both depression
(Table II, OR 4.73; 95% CI 2.41-9.26) and anxiety (OR
5.42; 95% CI 2.48-11.80).
Female sex was associated with a greater odds of body im-
age dissatisfaction, after we adjusted for age, BMI, remission,
steroid use, anxiety, and depression (Table II, OR 2.31; 95%
CI 1.22-4.39). Patients with body image dissatisfaction were
significantly less likely to report remission than those
without body image dissatisfaction (43% vs 74%,
P < .001), and current remission did not confer decreased
odds of developing body image dissatisfaction (OR 0.61;
95% CI 0.32-1.18). Current steroid use did not confer an16.9
20.3
entile Quartile
Quartile 3 Quartile 4
51-75% 76-100%
porting body image dissatisfaction.
Table II. Multivariate ORs for body image
dissatisfaction among pediatric patients with IBD in
the IBD Partners: Kids & Teens Cohort
Characteristics aOR (95% CI)
Female sex* 2.31 (1.22-4.39)
Current steroid use† 1.59 (0.63-4.07)
Depression‡ 4.73 (2.41-9.26)
Anxiety§ 5.42 (2.48-11.80)
Current remission{ 0.61 (0.32-1.18)
Remission defined by pediatric Ulcerative Colitis Activity Index score <10 or a CDAI score <150.
*Adjusted for age, BMI, remission, steroid use, anxiety, depression.
†Adjusted for age, sex, BMI, remission, hospitalization, surgical status, anxiety, depression.
‡Adjusted for age, sex, BMI, remission, steroid use, hospitalization, surgical status, anxiety.
§Adjusted for age, sex, BMI, remission, steroid use, hospitalization, surgical status, depression.
{Adjusted for age, sex, BMI, hospitalization, surgical status, depression, anxiety.increased odds of reporting body image dissatisfaction after
we adjusted for confounders (OR 1.59; 95% CI 0.63-4.07).
Extra-intestinal manifestations were not significantly
associated with body image dissatisfaction in this cohort
(Table III; available at www.jpeds.com).
Discussion
We assessed body image dissatisfaction in a pediatric IBD
population using a large, geographically diverse, patient-
reported cohort. In this sample, 11.1% of respondents met
criteria for body image dissatisfaction. We identified
numerous risk factors for body image dissatisfaction in this
pediatric IBD population: active disease, steroid use, female
sex, older age at diagnosis, greater BMI percentile, anxiety,
and depression. Among these factors, adopting steroid-
sparing regimens, providing interventions to address comor-
bid mood disorders, and recommending nutritional support
services may represent modifiable targets to decrease body
image dissatisfaction. Further study should be devoted to
the validation of such interventions that improve HRQoL
for young patients with IBD.
A recent study of patients with IBD found that 16% war-
ranted a formal evaluation for an eating disorder.13 In this
study, 90% of patients responded to at least 1 question in a
manner indicating a pathologic attitude toward food. A qual-
itative study of children with IBD reported that children
perceive themselves to be alienated by their necessity to be
mindful of foods.9 Other quantitative work has shown that
age and body satisfaction are linked to a child’s likelihood
of adhering to a healthy diet that meets the demands of a
chronic illness.14 In a review of the psychosocial health of pe-
diatric patients with a number of chronic diseases, including
IBD, poor body image was shown to predict poor self-care
and disordered eating, exacerbating the detrimental effects
of disease and of medication-related malnutrition.9
Similar to studies in adult patients, our study demonstrated
that female patients with IBD had greater odds of body image
dissatisfaction.15–17 Although the general prevalence of body
image dissatisfaction among American adolescents has had
highly variable estimates, several large community-basedstudies assessing body image dissatisfaction among older ad-
olescents found a markedly greater prevalence among female
(24%-46%) compared with male (12%-26%) respondents.18
A review of the psychosocial sequelae of pediatric patients
with diet-related chronic health conditions similarly revealed
a pronounced difference by sex. For example, young female
patients with CF preferred lower body weights, even manipu-
lating pancreatic enzymes to minimize weight gain. Male pa-
tients with CF, however, rigorously followed nutritional
advice and supplemented their intake with anabolic steroids
to achieve more socially acceptable forms.9 Notably, despite
their enhanced odds of body image dissatisfaction, female pa-
tients with IBD have been shown to have no sex-specific dif-
ferences in severity of disease, BMI, height velocity, or
medication use, which could have explained this common dif-
ference in experienced body image.19
Comorbid anxiety and depression independently
conveyed increased odds of reporting body image dissatisfac-
tion in our study. Both anxiety and depression are prevalent
in patients of all ages with IBD, with previous work esti-
mating a lifetime prevalence of 30%-80%.20 The prevalence
of anxiety disorders among the general pediatric population
has been estimated at 13%, but among children with chronic
medical illnesses, this value may be as high as 40%.21
Although no age-matched norms for body image dissatisfac-
tion exist against which to compare our patients with IBD, a
large meta-analysis of 330 studies, albeit with heterogeneity
among comparators and methods, found overall slightly
greater rates of body image dissatisfaction among children
with chronic illnesses, including asthma, cystic fibrosis, can-
cer, and diabetes, have greater rates of body image dissatisfac-
tion.22 A small prospective study at a single center found
increased body image dissatisfaction among both IBD
compared with age-matched controls, although not
compared with age-matched patients with diabetes.23 In
contrast, a meta-analysis identified that youth with IBD
had worse HRQoL and social functioning compared with
other youth with chronic illnesses.24 In a 10-year study of
American teenagers aged 15-17 years, body image dissatisfac-
tion rates ranged from 12% to 46%, which corroborates that
as our cohort continues to follow our patients with IBD over
time, the older teenager population may represent a valuable
subgroup for further study.16 Body image dissatisfaction
among adult patients with IBD has been shown to remain
constant over time, regardless of disease activity.15 These
data, along with our findings, support the importance of
identifying children with IBD and risk factors for body image
dissatisfaction as candidates for novel protective interven-
tions.
Our data are drawn from a large, geographically diverse
patient cohort. Further, the psychosocial metrics included
in the surveys are well-validated instruments and have been
shown to correlate linearly and meaningfully with clinical
outcomes in this population. Our ability to assess validated
scales of depression and anxiety also enriches this study.
Among the limitations to this study are its cross-sectional
design, which makes any assessment of causality difficult. We
consider these findings hypothesis-generating. That 89% of 
our study participants identified as white limits the general-
ization of our findings to other ethnicities. We chose to use a 
single-question, binary assessment of body image dissatisfac-
tion rather than a larger scale, such as the body image distur-
bance questionnaire, or qualitative patient responses. 
Beneficially, this question from IMPACT-III is validated in 
all pediatric populations, compared with more disease- or 
treatment-specific alternatives. Data from Kids & Teens are 
via self-report, including measurements of height, weight, 
and disease remission; because no pediatric measurements 
of Crohn’s activity have been validated by self-report, we 
used the CDAI, which was validated in adult patients. At 
baseline, most of the patients with UC in our study were in 
remission, and most of our patients with CD had mild dis-
ease, leading to a potential for underrepresenting patients 
with more active disease. Misclassification is possible. Still, 
a validation study in a sample of the adult IBD Partners 
cohort demonstrated >97% accuracy of IBD diagnosis on 
comparison with medical records.10 Finally, the small 
numbers of respondents reporting pouches and ostomies un-
derpowered our analyses of these subgroups, despite their 
possible clinical import.
Future directions for our cohort include longitudinal anal-
ysis of the features of body image dissatisfaction among pa-
tients with IBD over time and more specific analysis among 
patients aged 15-17 years, who may have the greatest rates 
of body image dissatisfaction in the general American popu-
lation, as our participants continue to track their HRQoL and 
disease outcomes via survey. Early and frequent clinical 
assessment of unmet psychiatric needs, initiation of steroid-
sparing therapies, nutritional counseling, and physical activ-
ity are potential interventions to prevent or improve body im-
age dissatisfaction among pediatric patients with IBD.
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Table III. Presence of body image dissatisfaction




present (n = 57), %
No body image
dissatisfaction
(n = 451), % P value
Arthralgias 45.6 34.6 .10
Erythema nodosum 7.0 2.9 .10
Pyoderma gangrenosum 0 0.4 .614
Ocular 10.5 6 .19
Aphthous ulcers 19.3 8.9 .014
Primary sclerosing
cholangitis
0 1.6 .34
